Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Tachezy, Ruth ^a   Smahelova, Jana ^a   Kaspirkova, Jana ^b   Salakova, Martina ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b BIOPTICAL LABORATORY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALPHAPAPILLOMAVIRUS; CZECH REPUBLIC; DNA, VIRAL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; MIDDLE AGED; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84893360460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079156     Document Type: Article

References (28)

1. Walboomers JM, Meijer CJ (1997) Do HPV-negative cervical carcinomas exist? J Pathol 181: 253-254. doi:10.1002/(SICI)1096-9896(199703)181:3. PubMed: 9155707.
2. zur Hausen H (1996) Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78. PubMed: 8876633.
3. Gillison ML, Shah KV (2003) Role of mucosal human papillomavirus in nongenital cancers chapter 57. J Natl Cancer Inst Monogr: 65. PubMed: 12807947
4. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L et al. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7: 453-459. doi:10.1016/S1473-3099(07)70158-5. PubMed: 17597569.
5. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX et al. (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789-1799. doi:10.1086/657321. PubMed: 21067372.
6. Tachezy R, Hamsíková E, Hájek T, Mikysková I, Smahel M et al. (1999) Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol 58: 378-386. doi:10.1002/ (SICI)1096- 9071(199908)58:4. PubMed: 10421405.
7. Tachezy R, Davies P, Arbyn M, Rob L, Lazdane G et al. (2008) Consensus recommendations for cervical cancer prevention in the Czech Republic: a report of the International Conference on Human Papillomavirus in Human Pathology (Prague, 1-3 May 2008). J Med Screen 15: 207-210. doi:10.1258/jms.2008.008057. PubMed: 19106262.
8. Bulletin of Ministry of Public Health (2004) 7: 7-11
9. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M et al. (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30 Suppl 5: F88-F99. doi:10.1016/j.vaccine. 2012.06.095. PubMed: 23199969.
10. Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Rozendaal L et al. (2012) HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer 106: 975-981. doi:10.1038/bjc. 2011.581. PubMed: 22251922.
11. Harper DM (2009) Currently approved prophylactic HPV vaccines. Expert Rev Vaccines 8: 1663-1679. doi:10.1586/erv.09.123. PubMed: 19943762.
12. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D et al. (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287: 2114-2119. doi:10.1001/jama. 287.16.2114. PubMed: 11966386.
13. Schmitt M, Dondog B, Waterboer T, Pawlita M (2008) Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 46: 1050-1059. doi:10.1128/JCM.02227-07. PubMed: 18199790.
14. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ et al. (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779-787. doi:10.1128/JCM.40.3.779-787.2002. PubMed: 11880393.
15. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M et al. (2006) Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 44: 504-512. doi:10.1128/JCM.44.2.504-512.2006. PubMed: 16455905.
16. Tachezy R, Mikysková I, Ludvíková V, Rob L, Kucera T et al. (2006) Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies. Eur J Clin Microbiol Infect Dis 25: 492-500. doi:10.1007/s10096-006- 0172-5. PubMed: 16896828.
17. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA et al. (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125: 2151-2158. doi:10.1002/ijc.24528. PubMed: 19585494.
18. Bernard HU, Burk RD, Chen Z, Van DK, Hausen H et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79. doi:10.1016/j.virol.2010.02.002. PubMed: 20206957.
19. IARC Monograph Working Group (2007). IARC Monogr Eval Carcinog Risks Hum. 90: 1-636. PubMed: 18354839
20. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527. doi: 10.1056/NEJMoa021641. PubMed: 12571259.
21. Eklund C, Zhou T, Dillner J (2010) Global proficiency study of human papillomavirus genotyping. J Clin Microbiol 48: 4147-4155. doi:10.1128/JCM. 00918-10. PubMed: 20844222.
22. Eklund C, Forslund O, Wallin KL, Zhou T, Dillner J (2012) The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol 50: 2289-2298. doi:10.1128/JCM. 00840-12. PubMed: 22535980.
23. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-998. doi: 10.1016/S0140-6736(05) 67069-9. PubMed: 16168781.
24. Učakar V, Poljak M, Klavs I (2012) Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 30: 116-120. doi:10.1016/j.vaccine.2011.10.066. PubMed: 22080175.
25. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J et al. (2013) Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. Int J Cancer 132: 2395-2403. doi:10.1002/ijc.27891. PubMed: 23034864.
26. Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB et al. (2007) Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol 79: 771-781. doi:10.1002/jmv.20839. PubMed: 17457909.
27. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M et al. (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44: 557-564. doi: 10.1016/j.ejca.2007.12.001. PubMed: 18191395.
28. Tachezy R, Smahelova J, Salakova M, Arbyn M, Rob L et al. (2011) Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLOS ONE 6: e21913. doi: 10.1371/journal.pone. 0021913. PubMed: 21765924.